European Brain Council
Past Board Members
Paul Arteel |
Paul Arteel is Secretary General of the Global Alliance of Mental Illness Advocacy networks (GAMIAN Europe), Belgian Member of the World Federation for Mental Health (WFMH), Flemish Member of Mental Health Europe, member of the Human Rights Committee, Belgian delegate in Council and treasurer of the Comité Européen Droit Éthique et Psychiatrie (CEDEP) and co-founder and treasurer of the Belgian Schizophrenia Ligue. Mr Arteel, a qualified solicitor, is active in the fields of Patients Rights and Advocacy in Mental Health and anti stigma campaigns and image building on mental health. |
Dr Alastair Benbow |
Dr Alastair Benbow is Vice President and European Medical Director of GlaxoSmithKline (GSK). He is also the company’s media spokesperson on medical/clinical issues. His previous roles within GSK have included Vice President and Head of European Clinical Psychiatry, Vice President for European Government Affairs and Public Policy and Vice President and UK Medical Director. |
Mr Rodney Elgie |
Mr Rodney Elgie is past President of GAMIAN-Europe. He is Vice President of the European Men's Health Forum, a member of the boards of the International Society for Bipolar Disorders (ISBD), the European Platform for Patients' Organisations, Science and Industry, the Health Coalition Initiative, the General Medical Council’s Patient Reference Group and the Institut des Sciences de la Santé. A lawyer by profession, he became involved in patient advocacy after suffering from clinical depression in 1990. |
Prof. Tamás Freund |
Prof. Tamás Freund is President of the Federation of European Neuroscience Societies (FENS), Director of the Institute of Experimental Medicine at the Hungarian Academy of Sciences in Budapest and Head of its Cellular and Network Neurobiology Department. He is also Chairman of the Neuroscience Department of the Péter Pázmány Catholic University in Budapest. His research interests include the synaptic and molecular organisation, functional architecture and physiology of neuronal circuits in the cerebral cortex. |
Dr Jo Lissens |
Dr Jo Lissens is Research Director for Neurological Business at Medtronic Europe in Tolochenaz, Switzerland, and represents the medical device industry on the EBC Board. |
Prof. Andrew Maas |
Prof. Andrew Maas is Chair of the Residency Programme and Director of Neurological Research at the Department of Neurosurgery attached to Erasmus MC, Rotterdam, the Netherlands. He is also Chairman of the European Brain Injury Consortium and a member of the Neurotraumatology Committee of the World Federation of Neurosurgical Societies. His research is mainly in the field of neurotraumatology. |
Prof. Richard Morris |
Prof. Richard Morris is President of the Federation of European Neuroscience Societies, professor of neuroscience at the University of Edinburgh, UK and an adjunct professor of the Norwegian Technical University in Trondheim. He is a member of the Council of the European Dana Alliance for the Brain and has actively promoted the public awareness of science throughout his career. His principal research interest is the neurobiology of learning and memory, but he is also interested in the use of brain imaging techniques. |
Prof. Paolo Morselli |
Prof. Paolo Morselli acts on a pro bono basis as Secretary General of GAMIAN-Europe, of which he was a founding member. He is also a member and former Vice President of the ISBD. His research interests include social and therapeutic aspects of mental disorders and the role of patient advocacy groups in the long-term management of the psychiatric patient. He worked for many years in the pharmaceutical industry. |
Christoph Pedain |
Dr. Christoph Pedain is Director, R&D Medical Data Enrichment at BrainLAB AG, Germany. At BrainLAB, Christoph heads the research and product development for a variety of medical image analysis technologies, primarily focused on diagnosis and therapy of neurodegenerative diseases as well as brain cancer. Furthermore, he is Secretary-Treasurer of the Society for CNS Interstitial Delivery of Therapeutics. One of Christoph’s main interests lies in the interface between software and pharma/biotech, thereby creating new routes for the delivery of therapeutics to the brain. |
Prof. Asla Pitkänen |
Prof. Asla Pitkänen is Secretary General of FENS and Professor of Neurobiology at the AI Virtanen Institute for Molecular Sciences at the University of Kuopio, Finland. She is also a Vice Chair of the Finnish Epilepsy Society and a member of the Neurobiology Commission of the International League Against Epilepsy. Her research interests include molecular and cellular mechanisms of epileptogenesis. |
Dr Andrew Sleight |
Dr Andrew Sleight is the Global Head of Neuroscience Research for Hoffmann-La Roche and is based in Basel, Switzerland. During his career in the pharmaceutical industry he has led discovery teams that have successfully tested molecules in clinical studies in brain diseases (both psychiatric and neurological disorders). |
Prof. Jan van Ree |
Prof. Jan M. van Ree is director of the Rudolf Magnus Institute of Neuroscience and professor of psychopharmacology at the Utrecht University and the University Medical Centre Utrecht, the Netherlands. He is chair of ECNP’s Publication Committee, a founder of the Netherlands Brain Foundation and the Netherlands Decade of the Brain. His research interests include experimental addiction, behavioural pharmacology, social behaviour, neuropeptides and endogenous opioids. |
Copyright © 2007 European Brain Council All rights reserved.